| Literature DB >> 20356737 |
Steven M Ronkin1, Michael Badia, Steve Bellon, Anne-Laure Grillot, Christian H Gross, Trudy H Grossman, Nagraj Mani, Jonathan D Parsons, Dean Stamos, Martin Trudeau, Yunyi Wei, Paul S Charifson.
Abstract
Bacterial DNA gyrase is an attractive target for the investigation of new antibacterial agents. Inhibitors of the GyrB subunit, which contains the ATP-binding site, are described in this communication. Novel, substituted 5-(1H-pyrazol-3-yl)thiazole compounds were identified as inhibitors of bacterial gyrase. Structure-guided optimization led to greater enzymatic potency and moderate antibacterial potency. Data are presented for the demonstration of selective enzyme inhibition of Escherichia coli GyrB over Staphylococcus aureus GyrB. 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20356737 DOI: 10.1016/j.bmcl.2010.03.052
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823